Exploring the Industrial Value of the Portuguese Deep Sea Microorganisms

Catia Rodrigues (), Ana Martins (), Goncalo Andrade (), Marta Cerejo (), Ricardo Pinheiro (), Patricia Calado () and Helena Vieira ()
Additional contact information
Catia Rodrigues: BIOALVO S.A., Postal: BIOALVO S.A., Edifício ICAT, Campus FCUL, Campo Grande, Lisboa, Portugal
Ana Martins: BIOALVO S.A., Postal: BIOALVO S.A., Edifício ICAT, Campus FCUL, Campo Grande, Lisboa, Portugal
Goncalo Andrade: BIOALVO S.A., Postal: BIOALVO S.A., Edifício ICAT, Campus FCUL, Campo Grande, Lisboa, Portugal
Marta Cerejo: BIOALVO S.A., Postal: BIOALVO S.A., Edifício ICAT, Campus FCUL, Campo Grande, Lisboa, Portugal
Ricardo Pinheiro: BIOALVO S.A., Postal: BIOALVO S.A., Edifício ICAT, Campus FCUL, Campo Grande, Lisboa, Portugal
Patricia Calado: BIOALVO S.A., Postal: BIOALVO S.A., Edifício ICAT, Campus FCUL, Campo Grande, Lisboa, Portugal
Helena Vieira: BIOALVO S.A., Postal: BIOALVO S.A., Edifício ICAT, Campus FCUL, Campo Grande, Lisboa, Portugal

No 2011-15, Spatial and Organizational Dynamics Discussion Papers from CIEO-Research Centre for Spatial and Organizational Dynamics, University of Algarve

Abstract: The interest in the usage of marine natural sources for bioactive discovery has increased tremendously in the last decade. BIOALVO owns a unique collection of more than 100 prokaryotic extremophiles isolated from deep sea hydrothermal vents in the Mid Atlantic Rift, near the Azores Islands. The extreme conditions of temperature and chemical composition of those vents make these microorganisms potential sources for bioactive compounds. Based on this assumption, a collection of both aqueous and organic extracts produced from those microorganisms, entitled PharmaBUG, has been tested for both pharmaceutical and cosmetic usages in BIOALVO’s internal research projects and also in collaboration with partners. In order to expand the PharmaBUG library, new strains are being selected based on the diversity of environments from which they derive. The expanded collection is expected to reach 100.000 extracts, at the end of 2013. BIOALVO presents itself as a one-stop-shop for natural product development, based not only on its extensive, yet continuously expanding, comprehensive natural extract library and corresponding bioactivities, but also on expert and customizable assay development, which can be coupled to an in-house robotized screening facility, effectively speeding up the testing process and bringing a natural product solution closer and quicker to market

Keywords: BIOALVO; GPS D2© Technology; Marine Natural Extracts; PharmaBUG collection (search for similar items in EconPapers)
JEL-codes: Q57 (search for similar items in EconPapers)
Pages: 10 pages
Date: 2011-11-30
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.cieo.pt/discussionpapers/8/article8.pdf Full text (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ris:cieodp:2011_015

Access Statistics for this paper

More papers in Spatial and Organizational Dynamics Discussion Papers from CIEO-Research Centre for Spatial and Organizational Dynamics, University of Algarve University of Algarve, Faculty of Economics, Campus de Gambelas, 8005-139 Faro, Portugal, email of President of the Centre: mtvaz@ualg.pt. Contact information at EDIRC.
Bibliographic data for series maintained by Silvia Fernandes ().